Research and Markets: Europe Therapeutic Drug Monitoring (TDM) Market Report 2016: Forecasts, Technologies & Strategies – France, Germany, Italy, Spain, UK

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/2qj27p/2016_europe)
has announced the addition of the “2016
Europe Therapeutic Drug Monitoring (TDM) Market: Test Volume and Sales
Country Segment Forecasts, Innovative Technologies, Competitive
Strategies–France, Germany, Italy, Spain, UK”
report to their
offering.

This new 291-page report from provides a comprehensive analysis of the
European therapeutic drug monitoring market, including emerging tests,
technologies, instrumentation, sales forecasts, market shares, and
strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and
market segment for the following assays: Amikacin, Carbamazepine,
Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium,
Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine,
Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic
Acid and Vancomycin.

During the next five years, the TDM market will undergo significant
transformation. These changes will be caused by convergence of new and
more stringent regulations; advances in diagnostic technologies, system
engineering, automation, and IT; and intensifying competition. Some
segments will start resembling commodity markets, where product
positioning and cost per test are more critical than underlying
technology. This evolving marketplace will create exciting opportunities
for a variety of new instruments, reagent systems, and auxiliary
products, such as specimen preparation devices, controls, calibrators
and others.

This unique market and technology assessment is designed to help current
suppliers and potential market entrants identify and evaluate emerging
opportunities and developed effective strategic responses. The study
provides five-year forecasts for major TDM assays; compares features of
leading analyzers; and profiles key competitors.

Contains 291 pages and 61 tables

Companies Mentioned:

  • Abbott Laboratories
  • AdnaGen/Alere
  • Agilent Technologies
  • Bayer Healthcare
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

For more information visit http://www.researchandmarkets.com/research/2qj27p/2016_europe

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In
Vitro Diagnostics